Recherche
-
The impact of artificial intelligence on retinal disease management: Vision Academy retinal expert consensus
(Current Opinion in Ophthalmology. vol. 34, n° 5, pp. 396-402, 2023-09-01)Article de revueLibre accès -
Microperimetry to predict disease progression in eyes at high risk of age-related macular degeneration disease: The PREVISION study
(Acta Ophthalmologica. vol. 101, n° 2, pp. e135-e142, 2023-03)Article de revueLibre accès -
Retinal microvasculature and incident dementia over 10 years: The Three-City-Alienor cohort
(Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring. vol. 15, n° 4, pp. e12480, 2023-10)Article de revueLibre accès -
Pegcetacoplan for the treatment of geographic atrophy secondary to age-related macular degeneration (OAKS and DERBY): two multicentre, randomised, double-masked, sham-controlled, phase 3 trials
(The Lancet. vol. 402, n° 10411, pp. 1434-1448, 2023-10-21)Article de revue -
Age-related macular degeneration and loss of autonomy : the Alienor-3C Study
Communication dans un congrès -
Association of retinal nerve layers thickness and brain imaging in healthy young subjects from the i-Share-Bordeaux study
(Human Brain Mapping. vol. 44, n° 13, pp. 4722-4737, 2023-09-01)Article de revueLibre accès -
Traitements médicaux de la rétine : 2023, année charnière
(Journal Français d'Ophtalmologie. vol. 46, n° 8, pp. 839-840, 2023-10-01)Article de revue -
Association of Age-Related Macular Degeneration with a Blood Biomarker of Lipopolysaccharide, a Gut Bacterial Proinflammatory Toxin
(Investigative Ophtalmology & Visual Science. vol. 64, n° 14, pp. 47, 2023-11-01)Article de revueLibre accès -
Faricimab Treat-and-Extend for Diabetic Macular Edema: 2-Year Results from the Randomized Phase 3 YOSEMITE and RHINE Trials
(Ophthalmology: Journal of The American Academy of Ophthalmology, 2023-12-27)Article de revueLibre accès